The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter

This study has been completed.
Sponsor:
Information provided by:
Copenhagen University Hospital at Herlev
ClinicalTrials.gov Identifier:
NCT01384786
First received: June 28, 2011
Last updated: NA
Last verified: June 2011
History: No changes posted
  Purpose

Patients with hyperthyroidism and/or goiter are evaluated with blood samples and scintiscan before they are treated with radioiodine for their thyroid disease. Because the investigators do not get a histologically/final diagnosis the investigators want to make sure, that the patients treated do not have a thyroid cancer when treated.

The investigators have found that thyroid cancer is not overlooked.


Condition
Hyperthyreosis and Goiter
Thyroid Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter

Resource links provided by NLM:


Further study details as provided by Copenhagen University Hospital at Herlev:

Enrollment: 4474
Study Start Date: October 2004
Study Completion Date: July 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Radioiodine treated patients

Criteria

Inclusion Criteria:

  • all patients treated with radioiodine
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01384786

Locations
Denmark
herlev Hospital
Copenhagen, Denmark
Sponsors and Collaborators
Copenhagen University Hospital at Herlev
Investigators
Study Chair: Anders Vej-Hansen Herlev Hospital, Copenhagen, Denmark
  More Information

No publications provided

Responsible Party: Birte Nygaard md PhD, dept of endocinology O 106
ClinicalTrials.gov Identifier: NCT01384786     History of Changes
Other Study ID Numbers: JCEM070948
Study First Received: June 28, 2011
Last Updated: June 28, 2011
Health Authority: Denmark: Datatilsynet

Additional relevant MeSH terms:
Thyroid Diseases
Thyroid Neoplasms
Goiter
Hyperthyroidism
Endocrine System Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Head and Neck Neoplasms

ClinicalTrials.gov processed this record on October 19, 2014